Chemotherapy
- 1 March 1992
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 147 (3 Part 2) , 938-941
- https://doi.org/10.1016/s0022-5347(17)37428-1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The prostate: An increasing medical problemThe Prostate, 1990
- Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.The Journal of cell biology, 1988
- Prostatic Epidermal Growth Factor Receptors and Their Regulation by Androgens*Endocrinology, 1987
- Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.Proceedings of the National Academy of Sciences, 1987
- Stimulation by somatostatin of dephosphorylation of membrane proteins in pancreatic cancer MIA PaCa‐2 cell lineFEBS Letters, 1985
- Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude miceInternational Journal of Cancer, 1984
- The heterogeneous nature of metastatic neoplasms: Implications for the treatment of cancerUrology, 1984
- Adjuvant chemotherapy for stage D1 adenocarcinoma of prostateUrology, 1983
- SOMATOSTATIN INHIBITS RAPID CENTROSOMAL SEPARATION AND CELL PROLIFERATION INDUCED BY EPIDERMAL GROWTH FACTOR.Endocrinology, 1982